




MAP4K-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/MAP4K.html MAP4KMAPK Kinase Kinase KinaseMAP kinase kinase kinase kinases (MAP4Ks) belong to the mammalian Ste20-like family of serine/threonine kinases. MAP4Ksincluding MAP4K1/HPK1, MAP4K2/GCK, MAP4K3/GLK, MAP4K4/HGK, MAP4K5/KHS, and MAP4K6/MINK have been repo
2、rted toinduce JNK activation through activating the MAP3K-MAP2K cascade. MAP4Ks play important roles in the regulation of cellapoptosis, cell survival, cell autophagy, and cell migration. Several studies reported that MAP4Ks are involved in the regulation ofimmune-cell responses through JNK-independ
3、ent pathways.MAP4K1/HPK1 and MAP4K4/HGK play negative roles in T-cell activation and inflammatory responses. In contrast, MAP4K3/GLKplays a positive role in T-cell activation and autoimmune responses. Moreover, MAP4K1 downregulation and MAP4K3overexpression in T cells are involved in human autoimmun
4、e diseases such as psoriatic arthritis, rheumatoid arthritis (RA),adult-onset Stills disease, and SLE.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/MAP4K.html MAP4K HYPERLINK https:/www.MedChemE/Targets/MAP4K.html HYPERLINK https:/www.MedChemE/Targets/MAP4K.html Inhibitors HYPERLINK https:/ww
5、w.MedChemE/DMX-5804.html DMX-5804 HYPERLINK https:/www.MedChemE/DMX-5804.html HYPERLINK https:/www.MedChemE/GNE_220.html GNE HYPERLINK https:/www.MedChemE/GNE_220.html HYPERLINK https:/www.MedChemE/GNE_220.html 220Cat. No.: HY-111754 Cat. No.: HY-U00428DMX-5804 is a potent, orally active and selecti
6、veMAP4K4 ICinhibitor, with an 50 of 3 nM, a pIC50of 8.55 for human MAP4K4, less potent onMINK1/MAP4K6 (pIC , 8.18), and TNIK/MAP4K750(pIC , 7.96).50GNE-220 is a potent and selective inhibitor ofMAP4K4 with an IC of 7 nM.50Purity: 99.63%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10
7、 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/GNE_220_Hydrochloride.html GNE HYPERLINK https:/www.MedChemE/GNE_220_Hydrochloride.html HYPERLINK https:/www.MedChemE/GNE_220_Hydrochloride.html 220 HYPERLINK https:/www.MedChemE/GNE_220
8、_Hydrochloride.html HYPERLINK https:/www.MedChemE/GNE_220_Hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/GNE_220_Hydrochloride.html HYPERLINK https:/www.MedChemE/gne-1858.html GNE-1858Cat. No.: HY-U00428A Cat. No.: HY-135892GNE 220 (hydrochloride) is a potent and selectiveinhibitor o
9、f MAP4K4, with an IC of 7 nM.50GNE-1858 is a potent and ATP-competitivehematopoietic progenitor kinase-1 (HPK1)inhibitor, with IC s of 1.9 nM, 1.9 nM, and 4.550nM for wild-type and the active mimetic mutantsHPK1-TSEE and HPK1-SA, respectively.Purity: 98.33%Clinical Data: No Development ReportedSize:
10、 5 mg, 10 mg, 25 mgPurity: 99.0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/GNE-495.html GNE-495 HYPERLINK https:/www.MedChemE/GNE-495.html HYPERLINK https:/www.MedChemE/hpk1-in-10.html HPK1-IN-10Cat. No.: HY-100343 Cat. No.: HY-14
11、5036GNE-495 is a potent and selective MAP4K4inhibitor with an IC of 3.7 nM.50HPK1-IN-10 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein kinase cloned fromhematopoietic progenitor cells and belongs to theMAP4K family of mammalian Ste-20-related proteinkinases.Purity: 99.68%Clinical Dat
12、a: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/hpk1-in-11.html HPK1-IN-11 HYPERLINK https:/www.MedChemE/hpk1-in-11.html HYPERLINK https:/www.MedChemE/hpk1-in-12.html HPK1-IN-12Cat. No.: H
13、Y-145037 Cat. No.: HY-145038HPK1-IN-11 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein kinase cloned fromhematopoietic progenitor cells and belongs to theMAP4K family of mammalian Ste-20-related proteinkinases.HPK1-IN-12 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein k
14、inase cloned fromhematopoietic progenitor cells and belongs to theMAP4K family of mammalian Ste-20-related proteinkinases.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/hpk1-in-13.html H
15、PK1-IN-13 HYPERLINK https:/www.MedChemE/hpk1-in-13.html HYPERLINK https:/www.MedChemE/hpk1-in-14.html HPK1-IN-14Cat. No.: HY-145039 Cat. No.: HY-145040HPK1-IN-13 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein kinase cloned fromhematopoietic progenitor cells and belongs to theMAP4K fa
16、mily of mammalian Ste-20-related proteinkinases.HPK1-IN-14 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein kinase cloned fromhematopoietic progenitor cells and belongs to theMAP4K family of mammalian Ste-20-related proteinkinases.Purity: 98%Clinical Data: No Development ReportedSize:
17、1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/hpk1-in-15.html HPK1-IN-15 HYPERLINK https:/www.MedChemE/hpk1-in-15.html HYPERLINK https:/www.MedChemE/hpk1-in-16.html HPK1-IN-16Cat. No
18、.: HY-145041 Cat. No.: HY-145042HPK1-IN-15 is a potent and selective inhibitor ofHPK1. Hematopoietic progenitor kinase 1 (HPKl)originally cloned from hematopoietic progenitorcells is a member of MAP kinase kinase kinasekinases (MAP4Ks) family.HPK1-IN-16 is a potent and selective inhibitor ofHPK1. He
19、matopoietic progenitor kinase 1 (HPKl)originally cloned from hematopoietic progenitorcells is a member of MAP kinase kinase kinasekinases (MAP4Ks) family.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https
20、:/www.MedChemE/hpk1-in-17.html HPK1-IN-17 HYPERLINK https:/www.MedChemE/hpk1-in-17.html HYPERLINK https:/www.MedChemE/hpk1-in-18.html HPK1-IN-18Cat. No.: HY-145044 Cat. No.: HY-145045HPK1-IN-17 is a potent and selective inhibitor ofHPK1. Hematopoietic progenitor kinase 1 (HPKl)originally cloned from
21、 hematopoietic progenitorcells is a member of MAP kinase kinase kinasekinases (MAP4Ks) family.HPK1-IN-18 is a potent and selective inhibitor ofHPK1. Hematopoietic progenitor kinase 1 (HPKl)originally cloned from hematopoietic progenitorcells is a member of MAP kinase kinase kinasekinases (MAP4Ks) fa
22、mily.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/hpk1-in-19.html HPK1-IN-19 HYPERLINK https:/www.MedChemE/hpk1-in-19.html HYPERLINK https:/www.MedChemE/hpk1-in-20.html HPK1-IN-20Cat.
23、No.: HY-145107 Cat. No.: HY-145109HPK1-IN-19 is a hematopoietic progenitor kinase1 (HPK1) inhibitor extracted from patentWO2018102366A1 compound I-47.HPK1-IN-19 is a hematopoietic progenitor kinase1 (HPK1) inhibitor extracted from patentWO2020235902A1 compound 106.Purity: 98%Clinical Data: No Develo
24、pment ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/hpk1-in-21.html HPK1-IN-21 HYPERLINK https:/www.MedChemE/hpk1-in-21.html HYPERLINK https:/www.MedChemE/hpk1-in-24.html HPK1-IN-24Cat. No.: HY-144073 Cat. No.: HY-144091HPK1-I
25、N-21 is a potent inhibitor of HPK1 kinaseinhibitor (Ki=0.8 nM), HPK1-IN-21 also has orallyactive.HPK1-IN-24 (example 51) is a hematopoieticprogenitor kinase 1 (HPK1) inhibitor with a K ofi100 nM. HPK1-IN-24 has the potentialfor cancer research.Purity: 98%Clinical Data: No Development ReportedSize: 1
26、 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/hpk1-in-25.html HPK1-IN-25 HYPERLINK https:/www.MedChemE/hpk1-in-25.html HYPERLINK https:/www.MedChemE/hpk1-in-26.html HPK1-IN-26Cat. No.: HY-144092 Cat. No.: HY-144093HPK1-IN-25 (example 94) is
27、a hematopoieticprogenitor kinase 1 (HPK1) inhibitor with aenzymatic activity IC of 129 nM.50HPK1-IN-25 has the potential forcancer research.HPK1-IN-26 is a HPK1 and GLK inhibitor extractedfrom patent WO2021254118A1 compound 1. HPK1-IN-26can be used for the research of animal pathogeninfection.Purity
28、: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/hpk1-in-27.html HPK1-IN-27 HYPERLINK https:/www.MedChemE/hpk1-in-27.html HYPERLINK https:/www.MedChemE/hpk1-in-28.html HPK1-IN-28Ca
29、t. No.: HY-143868 Cat. No.: HY-143869HPK1-IN-27 is a potent inhibitor of HPK1. MAP4K1is also known as hematopoietic progenitor kinase 1(HPK1). MAP4K1 is a serine/threonine kinase andmember of the germinal center kinase family.HPK1-IN-28 is a potent inhibitor of HPK1.Hematopoietic progenitor kinase 1
30、 (HPK1) is anegative regulator of the activation response ofdendritic cells (DCs), T cells and B cells.HPK1-IN-28 enhances the bodys anti-tumorimmunity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/
31、www.MedChemE/hpk1-in-29.html HPK1-IN-29 HYPERLINK https:/www.MedChemE/hpk1-in-29.html HYPERLINK https:/www.MedChemE/hpk1-in-3.html HPK1-IN-3Cat. No.: HY-143870 Cat. No.: HY-138568HPK1-IN-29 is a potent inhibitor of HPK1.Hematopoietic progenitor kinase 1 (HPK1) is anegative regulator of the activatio
32、n response ofdendritic cells (DCs), T cells and B cells.HPK1-IN-29 enhances the bodys anti-tumorimmunity.HPK1-IN-3 is a potent and selectiveATP-competitive hematopoietic progenitor kinase1 (HPK1; MAP4K1) inhibitor with an IC of 0.2550nM. HPK1-IN-3 has IL-2 cellular potency with anEC of 108 nM in hum
33、an peripheral blood50mononuclear cells (PBMCs).Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.53%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/hpk1-in-30.html HPK1-IN-30 HYPERLINK https:/www.MedChemE/hpk1-in-3
34、0.html HYPERLINK https:/www.MedChemE/hpk1-in-4.html HPK1-IN-4Cat. No.: HY-143871 Cat. No.: HY-138569HPK1-IN-30 is a potent inhibitor of HPK1. MAP4K1is also known as hematopoietic progenitor kinase 1(HPK1). MAP4K1 is a serine/threonine kinase andmember of the germinal center kinase family.HPK1-IN-4 (
35、comp 22) is a HPK1 (MAPK41)inhibitor (IC of 0.061 nM) as preclinical50immunotherapy tool compound.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.09%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/hpk1-in-7.html
36、HPK1-IN-7 HYPERLINK https:/www.MedChemE/hpk1-in-7.html HYPERLINK https:/www.MedChemE/hpk1-in-8.html HPK1-IN-8Cat. No.: HY-138742 Cat. No.: HY-132926HPK1-IN-7 is a potent, orally active HPK1(hematopoietic progenitor kinase 1, MAP4K1)inhibitor (IC =2.6 nM) with excellent family and50kinome selectivity
37、. HPK1-IN-7 shows selectivityagainst IRAK4 (59 nM) and GLK (140 nM).HPK1-IN-8 is an allosteric, inactiveconformation-selective inhibitor of full-lengthHPK1.Purity: 99.61%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize
38、: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/hpk1-in-9.html HPK1-IN-9 HYPERLINK https:/www.MedChemE/hpk1-in-9.html HYPERLINK https:/www.MedChemE/ky-05009.html KY-05009Cat. No.: HY-145035 Cat. No.: HY-124745HPK1-IN-9 is potent inhibitor of HPK1. HPK1 is aserine/threonine protein
39、kinase cloned fromhematopoietic progenitor cells and belongs to theMAP4K family of mammalian Ste-20-related proteinkinases.KY-05009 is an ATP-competitive Traf2- andNck-interacting kinase (TNIK) inhibitor with a Kiof 100 nM. KY-05009 pharmacologically inhibitsTGF-1-induced epithelial-to-mesenchymaltr
40、ansition (EMT) in human lung adenocarcinomacells.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.80%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 25 mg, 100 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/map4k4-i
41、n-3.html MAP4K4-IN-3 HYPERLINK https:/www.MedChemE/map4k4-in-3.html HYPERLINK https:/www.MedChemE/NCB-0846.html NCB-0846Cat. No.: HY-125012 Cat. No.: HY-100830MAP4K4-IN-3 (Compound 17) is a potent andselective MAP4K4 inhibitor with an IC of 14.950nM in kinase assay, an IC of 470 nM in cell50assay. A
42、ntidiabetic agent.NCB-0846 is an orally available TNIK inhibitor withan IC of 21nM.50Purity: 99.13%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.36%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/NG25.html NG25 HYPERLINK https:/www.MedChemE/NG25.html HYPERLINK https:/www.MedChemE/PF-06260933.html PF-06260933Cat. No.: HY-1543
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 面?zhèn)鋺?zhàn)演出經(jīng)紀(jì)人考證
- 演出合同的重要條款試題及答案
- 解析2024年演出經(jīng)紀(jì)人資格證的真題試題及答案
- 演出經(jīng)紀(jì)人資格證信息檢索及試題及答案
- 西美實(shí)驗(yàn)藝術(shù)考題及答案
- 建省寧德市福鼎一中2024年中考數(shù)學(xué)最后沖刺濃縮卷含解析
- 語(yǔ)文教輔面試題及答案
- 南京中醫(yī)藥大學(xué)《設(shè)計(jì)方法與市場(chǎng)策略研究》2023-2024學(xué)年第二學(xué)期期末試卷
- 成都信息工程大學(xué)《石油化工安全》2023-2024學(xué)年第二學(xué)期期末試卷
- 2025屆湖南省十三校高三下學(xué)期第四次模擬考試物理試題試卷含解析
- 第7章-可持續(xù)發(fā)展的評(píng)價(jià)指標(biāo)體系
- 風(fēng)電混塔安裝技術(shù)方案
- 《測(cè)繪管理法律與法規(guī)》課件-測(cè)繪資質(zhì)管理
- 礦山災(zāi)害與事故應(yīng)急預(yù)案
- 電力法律法規(guī)及案例分析知識(shí)講座
- 保險(xiǎn)行業(yè)職業(yè)道德培訓(xùn)
- 新能源汽車技術(shù)(第2版)高職全套教學(xué)課件
- 玩轉(zhuǎn)微木工:零基礎(chǔ)木作小件
- 漢字來(lái)歷的小故事hzlaili
- 中國(guó)數(shù)據(jù)中心產(chǎn)業(yè)發(fā)展白皮書(2023年)
- 子宮內(nèi)膜異位癥的疼痛管理
評(píng)論
0/150
提交評(píng)論